Explore the performance of IntelliCap.

Study identifier:D1840M00044

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A randomised, open-label, 4-way crossover study in healthy subjects to explore the performance of IntelliCap® by comparing pharmacokinetic profiles of a probe drug.

Medical condition

Plasma concentration

Phase

N/A

Healthy volunteers

Yes

Study drug

IntelliCap

Sex

Male

Actual Enrollment

20

Study type

Interventional

Age

18 Years - 50 Years

Date

Study Start Date: 01 Jan 2014
Primary Completion Date: 01 Mar 2014
Study Completion Date: 01 Mar 2014

Study design

Allocation: Randomized
Endpoint Classification: N/A
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Basic Science

Verification:

Verified 01 Jan 2016 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria